Research Article

Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation in relation to the Patients’ Age: Results from a Large Real-World Multicenter Observational Project

Table 2

Procedural and safety characteristics (N = 2534) by age groups divided into quartiles.

Procedural characteristicsTOTAL
(n = 2534)
Age <53
(n = 584)
Age 53–61
(n = 630)
Age 61–67
(n = 594)
Age ≥67
(n = 726)
value

Procedure duration (min)106.2 ± 46.5110.0 ± 49.6108.1 ± 45.8104.0 ± 45.2103.4 ± 45.30.064
Fluoroscopy time (min)28.5 ± 27.428.5 ± 14.729.8 ± 48.027.8 ± 15.728.0 ± 15.51.000
Ablation time (min)25.0 ± 17.526.0 ± 19.126.0 ± 17.223.9 ± 16.724.1 ± 17.00.0254,5
% Of isolated PVs (n treated veins/n target veins)98.1% (9547/9729)96.7% (2200/2269)98.6% (2371/2404)98.3% (2222/2261)98.5% (2754/2795)<0.0011,2,3
Left atrium dwell time (min)57.0 ± 26.759.8 ± 28.558.1 ± 27.255.9 ± 26.054.8 ± 25.10.150
Patients with at least one complication4.1% (104)3.8% (22)3.8% (24)4.0% (24)4.7% (34)1.000
Permanent diaphragmatic paralysis0.0% (1)0.2% (1)0.0% (0)0.0% (0)0.0% (0)1.000
Transient diaphragmatic paralysis1.8% (46)1.5% (9)2.2% (14)1.9% (11)1.7% (12)1.000
Pericardial effusion0.2% (6)0.3% (2)0.0% (0)0.0% (0)0.6% (4)0.610
Femoral arterio-venous fistula0.3% (7)0.5% (3)0.0% (0)0.2% (1)0.4% (3)1.000
Cardiac tamponade0.3% (7)0.2% (1)0.2% (1)0.3% (2)0.4% (3)1.000
Pneumothorax/Hemothorax0.0% (0)0.0% (0)0.0% (0)0.0% (0)0.0% (0)
Femoral pseudoaneurism0.1% (3)0.0% (0)0.2% (1)0.2% (1)0.1% (1)1.000
TIA0.2% (3)0.0% (0)0.2% (1)0.0% (0)0.1% (2)1.000
Hematoma0.4% (9)0.2% (1)0.3% (2)0.5% (3)0.4% (3)1.000
Other complication0.9% (22)0.9% (5)0.8% (5)1.0% (6)1.0% (6)1.000

1A significant difference between age<53 and age ≥53 and <61; 2a significant difference between age<53 and age ≥61 and <67; 3a significant difference between age<53 and age ≥67; 4a significant difference between age ≥53 and <61 and age ≥61 and <67; 5a significant difference between age ≥53 and <61 and age ≥67; 6a significant difference between age ≥61 and <67 and ag e≥67.